Circio Holding ASA
@circio.com
Circio Holding ASA (OSE:TRVX, to be changed to CRNA), a biotechnology company developing novel circular RNA and immunotherapy medicines.
Circio Holding ASA's Company Logos
Circio Holding ASA's Brand Colors
Hex Code
Color name
RGB
HSL
CMYK
#5943A1
Gigas
89, 67, 161
254, 41, 45
45, 58, 0, 37
#FFFFFF
White
255, 255, 255
0, 0, 100
0, 0, 0, 0
#330968
Windsor
51, 9, 104
267, 84, 22
51, 91, 0, 59
About Circio Holding ASA
Circio Holding ASA, a biotechnology company, is at the forefront of developing novel circular RNA and immunotherapy medicines. With a mission to activate the patient's immune system to fight cancer, Circio aims to bring tangible benefits to cancer patients who have limited treatment options. Their pipeline showcases promising clinical programs such as ONCOS-102 and the KRAS program, which have demonstrated impressive results, including a remarkable 35% response rate in PD-1 resistant melanoma.
By harnessing the power of circular RNA and leveraging their circVec platform, Circio is dedicated to addressing critical unmet medical needs and delivering value for their shareholders. Committed to transparency and corporate governance, Circio operates in accordance with the Norwegian Transparency Act and upholds a robust Code of Conduct. With an emphasis on research, collaboration, and innovation, Circio's dedicated team is focused on building next-generation RNA therapeutics to transform the landscape of cancer treatment
Company type
Public Company
Year founded
2010
Company size
11-50 employees
Related Brands
Tags
Circular RNA therapeutics
AAV gene therapy
CAR T cell therapy
Nucleic acid expression systems
Vector-based gene delivery
